Rapiblyk
Payments companies reported to CMS as associated with Rapiblyk. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Rapiblyk, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Rapiblyk
These are the largest totals companies reported as associated with Rapiblyk. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Chukwuka Okolo | Dallas, TX | Critical Care Medicine (Internal Medicine) | $5,176.10 |
| Arpana Bansal | Dallas, TX | Internal Medicine | $4,739.36 |
| Sherin John | Dallas, TX | Internal Medicine | $4,739.36 |
| Uyen-Thi Cao | Dallas, TX | Internal Medicine | $4,739.36 |
| Ali Bagheri | Dallas, TX | Hospitalist | $4,739.36 |
| Jeffrey Feiner | Laguna Hills, CA | Cardiovascular Disease | $4,134.66 |
| Sarah Malik | High Point, NC | Hospitalist | $3,934.68 |
| John Tremblay | Albany, NY | Cardiovascular Disease | $3,934.68 |
| Navindra Tajeshwar | Stony Brook, NY | Internal Medicine | $3,934.68 |
| Robert Millar | Albany, NY | Cardiovascular Disease | $3,934.68 |
Prescribed Rapiblyk?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.